Copart CEO Jeffrey Liaw sold 27,745 shares at a weighted-average $30.49 (about $846k total), reducing his direct stake by 22% under a Rule 10b5-1 plan. Post-sale, he still holds 99,641 shares (plus 178,718 derivative securities), and the trade price was slightly below the $30.69 close on July 28, 2026. With shares down 33.4% over 12 months and TTM revenue up 1% (EPS up ~6% to $1.61), the transaction appears more routine than a signal about near-term fundamentals.
This filing is a low-signal event: a pre-programmed sale from a CEO with substantial remaining direct and derivative exposure is not the kind of insider behavior that reliably predicts fundamentals. The market should care much more about the fact pattern underneath it: CPRT is transitioning from a compounding growth story to a slower-multiple, cash-generation story, which changes what the stock deserves to trade on. In that regime, brief headline-driven weakness usually gets bought only if the next operating update shows volume stabilization; otherwise, the de-rating can persist for several quarters.
The second-order effect is on relative performance inside auto remarketing. If CPRT’s top line stays in the low-single-digit zone, competitors and substitutes with more cyclicality or cheaper valuations can outperform simply because the market stops paying up for “quality growth.” That said, the current multiple already reflects a lot of deceleration, so an outright bearish stance is hard to justify unless there is evidence of worsening auction volumes, softer fee capture, or margin pressure. The contrarian miss here is that the real risk is not insider selling; it is that investors may be underestimating how much the stock’s premium depends on reaccelerating units rather than just preserving margins.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
-0.08
Ticker Sentiment
